The long-term agreement will accelerate the shift to using bio-identical ingredients across numerous L'Oréal product formulations and brands SAN DIEGO, July 2, 2024 /PRNewswire/ -- Debut, the biotech beauty leader and vertically integrated biotechnology company, announced today that it has signed an agreement with L'Oréal to develop more than a dozen vital, bio-identical ingredients that will replace conventionally sourced ingredients currently used in L'Oréal global beauty and personal care brands across skin, hair, color cosmetics and fragrance. .

这项长期协议将加速在众多欧莱雅产品配方和品牌中使用生物相同成分的转变。2024年7月2日，圣地亚哥/PRNewswire/--生物技术美容领导者和垂直整合生物技术公司今天宣布，它已与欧莱雅签署协议，开发十多种重要的生物相同成分，替代欧莱雅全球美容和个人护理品牌目前在皮肤、头发、彩色化妆品和香水中使用的常规来源成分。。

Continue Reading

继续阅读

Debut Founder and CEO Joshua Britton, Ph.D.

首次亮相创始人兼首席执行官约书亚·布里顿博士。

As part of the agreement, Debut will create new bio-based ingredients using proprietary advanced biomanufacturing processes which combine fermentation and cell-free technology to replace conventional methods.

作为协议的一部分，首次亮相将使用专有的先进生物制造工艺创造新的生物基成分，该工艺将发酵和无细胞技术相结合，以取代传统方法。

Green sciences such as Debut's breakthrough biotechnology processes unlock a new generation of cosmetic bioactive ingredients and products that marry the best of nature with supply chain transparency, safety, purity, consistency, quality and science-backed data.

绿色科学，如首秀突破性的生物技术工艺，开启了新一代化妆品生物活性成分和产品的大门，将大自然的精华与供应链的透明度、安全性、纯度、一致性、质量和科学支持的数据结合在一起。

'Creating bio-identical ingredients at scale helps preserve global biodiversity and secure responsible ingredient supply chains while continuing to prioritize quality and product performance,' said Debut Founder and CEO Joshua Britton, Ph.D. 'Debut is committed to creating bio-based formulations for all its beauty products and has unmatched capabilities in biotechnology, formulation and scaling to catalyze this transformative shift in beauty.' 'Through this exciting partnership and adoption of breakthrough technology, we are well-positioned to drive the creation of more sustainable and effective products that meet the demands of our consumers and fulfils our duty of care for the planet,' said Guive Balooch, Global Managing Director of Augmented Beauty and Open Innovation at L'Oréal Groupe.

“大规模生产生物相同成分有助于保护全球生物多样性，确保负责任的成分供应链，同时继续优先考虑质量和产品性能，”Destude创始人兼首席执行官约书亚·布里顿博士说。“Destudy致力于为其所有美容产品创建生物基配方，并在生物技术、配方和缩放方面具有无与伦比的能力，以催化这种美容的变革性转变。”欧莱雅集团（L'Oréal Groupe）增强美容和开放创新全球董事总经理吉夫·巴卢奇（GuiveBalooch）说，“通过这种令人兴奋的合作关系和突破性技术的采用，我们有能力推动创造更可持续和有效的产品，满足消费者的需求，履行我们对地球的关心义务。”。

'This long-term agreement with Debut is another example of our commitment to the Open Innovation ecosystem and building the future of beauty by collaborating with best-in-class partners.'The global beauty and personal care market is currently valued at $646 billion and projected to grow at an annual rate of 3.33%, according to Statista.

“这项与首次亮相的长期协议是我们致力于开放创新生态系统并通过与一流合作伙伴合作建设美丽未来的另一个例子。”据Statista统计，全球美容和个人护理市场目前价值6460亿美元，预计年增长率为3.33%。

In the face of climate change, worsening pollution and the unabating demand on natural resources, there is urgent need for sustainable ingredient sourcing. Synthetic biology, which Boston Consulting Group described as 'the manufacturing paradigm of the future', can deliver the innovation needed to create bio-identical, alternative ingredients for sustainable beauty.

面对气候变化、污染加剧和对自然资源的需求持续增长，迫切需要可持续的原料采购。波士顿咨询集团（Boston Consulting Group）将合成生物学称为“未来的制造范式”，它可以提供创造生物相同的替代成分以实现可持续美丽所需的创新。

By maintaining its laser-sharp focus on creating bio-based ingredients at the volume and quality needed, Debut is highly complementary to L'Oréal's global R&D efforts and a key partner towards meeting its L'Oréal for the Future sustainability commitments.Britton continued: 'Our mission is t.

通过保持其激光专注于以所需的数量和质量生产生物基成分，首次亮相是对欧莱雅全球研发工作的高度补充，也是实现欧莱雅未来可持续发展承诺的关键合作伙伴。布里顿继续说道：“我们的任务是t。